[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Allogeneic Hematopoietic Stem Cell Transplatation for CLL, CML, AML, ALL, Myelodysplasia and Non-Hodgkin's Lymphoma after Total Body Irradiation and Cyclophosphamide Conditioning or Cyclophosphamide and ATG Conditioning For Aplastic Anemia.

What is the purpose of the study? (in Layman's terms, please describe the study)

To provide allogeneic transplantation for patients with a matched related donor.

Upstate Institutional Review Board (IRB) Number:

251022

Study/Protocol ID:

BMT 9851

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Teresa C Gentile, MD, PhD

Who is eligible?

Diagnosis of ALL, CLL, CML, AML, Myelodyslasia and Non-Hodgkin's with a matched related donor, acceptable laboratory values, HIV negative, no serious or uncontrolled organ dysfunction.

What is involved if I participate?

  • How long is the study?
    Inpatient stay approximately 30 days, followed for lifetime.
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No
  • What tests and procedures are involved?
    Detailed history & physical to determine eligibility, laboratory tests, x-rays/scans, as necessary, bone marrow biopsy & aspirate as necessary, laboratory tests during hospital admission, dental clearance prior to transplant.

Where will the study take place?

SUNY Upstate Medical University,Syracuse, NY

Other Information:

Who can I contact for more information?

Name: Shramika Pokharel, MBBS, MPH
Phone: 315-464-8271
Email: pokhares@upstate.edu

Return to Previous Page || Search Again

Top